EX-10.2 2 immu-20170930ex102a57faf.htm EX-10.2Master Services Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH FIVE ASTERISKS (*****), HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
ContractMaster Services Agreement • November 9th, 2017 • Immunomedics Inc • In vitro & in vivo diagnostic substances
Contract Type FiledNovember 9th, 2017 Company IndustryCONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH FIVE ASTERISKS (*****), HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.